Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_assertion type Assertion NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_head.
- NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_assertion description "[High GCNs of MET and HGF associate with an increased risk of trastuzumab-based therapy failure in HER2-positive MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_provenance.
- NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_assertion evidence source_evidence_literature NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_provenance.
- NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_assertion SIO_000772 22850551 NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_provenance.
- NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_assertion wasDerivedFrom befree-20140225 NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_provenance.
- NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_assertion wasGeneratedBy ECO_0000203 NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_provenance.